Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

Orna and Ronen Neutra, parents of American-Israeli hostage killed by Hamas, joins Andrea Mitchell to discuss the recent ...

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and beta-thalassemia.

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

(RTTNews) - Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex Pharmaceuticals (VRTX) to utilize Orna's ...

Orna Therapeutics, Inc. ("Orna") and Shanghai Simnova Biotech Co., Ltd. ("Simnova") are pleased to announce the expansion of their strategic collaboration to include BCMA (B-cell maturation antigen) ...

Ronen and Orna Neutra, whose son Omer was killed by Hamas, join 'Fox & Friends Weekend' to discuss the cease-fire deal and ...

Ronan and Orna Neutra, the parents of an American held in Gaza, react to a possible cease-fire and hostage deal between ...

Vertex Pharmaceuticals will work together with Orna Therapeutics over the next three years to develop technology that would help enable “in vivo” gene therapies for sickle cell disease and ...

Vertex Pharmaceuticals and Orna Therapeutics have announced a three-year collaboration to develop next-generation gene therapies for sickle cell disease (SCD) and transfusion-dependent beta ...